UA19335A - Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу - Google Patents

Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу

Info

Publication number
UA19335A
UA19335A UA4831261A UA4831261A UA19335A UA 19335 A UA19335 A UA 19335A UA 4831261 A UA4831261 A UA 4831261A UA 4831261 A UA4831261 A UA 4831261A UA 19335 A UA19335 A UA 19335A
Authority
UA
Ukraine
Prior art keywords
preparation
treatment
deseasis
remedy
psoriasis type
Prior art date
Application number
UA4831261A
Other languages
English (en)
Russian (ru)
Inventor
Айбль Хансйорг
Унгер Клеменс
Енгель Юрген
Энгель Юрген
Original Assignee
Аста Медіка Аг
Аста Медика Аг
Макс-Планк-Гезельшафт Цур Фьордерунг Дер Віссеншафтен Е.Ф.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA19335(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Аста Медіка Аг, Аста Медика Аг, Макс-Планк-Гезельшафт Цур Фьордерунг Дер Віссеншафтен Е.Ф. filed Critical Аста Медіка Аг
Publication of UA19335A publication Critical patent/UA19335A/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід належить до хіміко-фармацевтичної промисловості і стосується способу виготовлення засобу для лікування захворювань типу псоріазу. Метою винаходу є підвищення ефективності дії.
UA4831261A 1989-09-27 1990-09-26 Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу UA19335A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (1)

Publication Number Publication Date
UA19335A true UA19335A (uk) 1997-12-25

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4831261A UA19335A (uk) 1989-09-27 1990-09-26 Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу

Country Status (17)

Country Link
EP (2) EP0916343A1 (uk)
JP (1) JP3176615B2 (uk)
CA (1) CA2026278C (uk)
DD (1) DD298052A5 (uk)
DE (1) DE4029747C2 (uk)
EG (1) EG19338A (uk)
FI (1) FI904726A7 (uk)
HU (1) HU209589B (uk)
IE (1) IE903464A1 (uk)
LT (1) LT3804B (uk)
LV (1) LV10391B (uk)
MC (1) MC2150A1 (uk)
NO (1) NO904184L (uk)
PT (1) PT95422B (uk)
RU (1) RU1837877C (uk)
UA (1) UA19335A (uk)
ZA (1) ZA907702B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
RU2190390C2 (ru) * 1998-01-22 2002-10-10 Центарис АГ Твердая фармацевтическая композиция для орального введения при лечении лейшманиоза и способ ее производства, фармацевтическая комбинация для лечения лейшманиоза у млекопитающих и способ лечения (варианты)
ES2175663T3 (es) * 1998-01-22 2002-11-16 Zentaris Ag Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
RU2196583C1 (ru) * 2001-05-29 2003-01-20 Барбинов Вячеслав Викторович Средство для наружной терапии псориаза и способ его изготовления
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
WO2011003430A1 (en) * 2009-07-09 2011-01-13 Expergen Drug Development Gmbh Liquid pharmaceutical form of alkylphosphocholine and method of preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
CA1280369C (en) * 1985-12-04 1991-02-19 Hansjorg Eibl Pharmaceutical with anti-tumor effect
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
FI904726A7 (fi) 1991-03-28
DE4029747A1 (de) 1991-04-11
IE903464A1 (en) 1991-04-10
LTIP1488A (en) 1995-06-26
FI904726A0 (fi) 1990-09-26
EP0419998A3 (en) 1991-10-23
LT3804B (en) 1996-03-25
EG19338A (en) 1994-12-30
PT95422A (pt) 1991-05-22
LV10391B (en) 1995-10-20
NO904184L (no) 1991-04-02
HUT55992A (en) 1991-07-29
DD298052A5 (de) 1992-02-06
EP0916343A1 (de) 1999-05-19
ZA907702B (en) 1991-07-31
PT95422B (pt) 1997-07-31
HU906233D0 (en) 1991-03-28
DE4029747C2 (de) 2003-10-02
RU1837877C (ru) 1993-08-30
JP3176615B2 (ja) 2001-06-18
LV10391A (lv) 1995-02-20
CA2026278C (en) 1996-04-30
JPH03130228A (ja) 1991-06-04
NO904184D0 (no) 1990-09-26
HU209589B (en) 1994-08-29
MC2150A1 (fr) 1992-03-10
CA2026278A1 (en) 1991-03-28
EP0419998A2 (de) 1991-04-03

Similar Documents

Publication Publication Date Title
AP9000206A0 (en) Treatment of conditions & diseases
ATA242288A (de) Dosierungsform für die behandlung kardiovaskulärer erkrankungen
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
DE3585981D1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
MY101842A (en) Treatment of oral diseases.
ZM9387A1 (en) Treatment of diseases caused by viruses
DE3568137D1 (en) Treatment of allergy
ZM3087A1 (en) Treatment of diseases caused by retroviruses
PT74928A (en) New anti-thromboticum based on polysachatides method for its preparation and pharmaceutical compositions
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
FR2556348B1 (fr) Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
KR100226082B1 (en) Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
AU2824289A (en) Thienotricyclene for the treatment of bronchial diseases
IT1247527B (it) Agente antiarteriosclerotico, sua preparazione ed uso
GR850815B (uk)
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
SU1238290A1 (ru) Способ получения препарата для лечения желудочно-кишечных заболеваний
IT8249656A0 (it) Preparato anti-infiammatorio nonsteroideo, per il trattamento delle affezioni artroreumatiche e metodo per la sua preparazione
ZA857722B (en) Process for treatment of diseases
DE69003532D1 (de) Therapeutische zusammensetzung und kit für die behandlung der rheumatischen polyarthritis.
ES2120573T3 (es) 24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis.
AU588547B2 (en) Process for treatment of diseases
AU588547C (en) Process for treatment of diseases